And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022
CMFRI Repository
View Archive InfoField | Value | |
Relation |
http://eprints.cmfri.org.in/16294/
https://www.business-standard.com/article/current-affairs/and-now-a-seaweed-based-nutraceutical-cure-for-fatty-liver-disease-122092701121_1.html |
|
Title |
And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022
|
|
Creator |
CMFRI, Library
|
|
Subject |
Seaweed
CMFRI News Clippings |
|
Description |
Kochi: The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds for the treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 percent natural bioactive ingredients extracted from seaweeds to improve liver health.
|
|
Publisher |
Business Standard
|
|
Date |
2022
|
|
Type |
Article
NonPeerReviewed |
|
Format |
text
|
|
Language |
en
|
|
Identifier |
http://eprints.cmfri.org.in/16294/1/Business%20Standard_27-09-2022.pdf
CMFRI, Library (2022) And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022. Business Standard. |
|